Expect to Use More "Concomitant" Quadruple Therapy for H. pylori

March 2017

You'll see changes in preferred drug regimens for H. pylori.

Triple therapy with a PPI and two antibiotics (Prevpac, etc) will fall out of favor. It's not as reliable now that clarithromycin resistance exceeds 15% in many parts of North America.

Expect to shift your prescribing based on new guidelines...to more use of QUADRUPLE therapy and treating for 14 days instead of 7 to 10 days.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Gastroenterology Expect to Use More "Concomitant" Quadruple Therapy for H. pylori
Cholesterol Stay Tuned to the LDL Controversy
Iron Start With Ferrous Sulfate or Ferrous Fumarate When Oral Iron Is Needed
Cardiology Dodge a "QT Storm" by Avoiding QT-Prolonging Meds In High-Risk Patients
Allergic Reactions Evaluate if Patients Are Really Allergic to Penicillin
Insulin Consider Lower-Cost Insulin Regimens
Women's Health Continue to Avoid ACE Inhibitors in Women Who May Become Pregnant
Asthma Ensure Patients Have Meds On Hand to Follow Their Asthma Action Plan
Pulmonary What to Expect With Meds for Pulmonary Arterial Hypertension
Travel Medicine Help Patients Prepare for Travel-Related Illnesses
Ear Health Tell Patients It's Usually Better to Leave Earwax Alone
Practice You'll soon see a new and improved website for Prescriber's Letter.

Expect to Use More "Concomitant" Quadruple Therapy for H. pylori

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents